ATE400602T1 - Verfahren zur herstellung von hydrogelen aus thiosulfonat-zusammensetzungen und ihre verwendungen - Google Patents

Verfahren zur herstellung von hydrogelen aus thiosulfonat-zusammensetzungen und ihre verwendungen

Info

Publication number
ATE400602T1
ATE400602T1 AT03800398T AT03800398T ATE400602T1 AT E400602 T1 ATE400602 T1 AT E400602T1 AT 03800398 T AT03800398 T AT 03800398T AT 03800398 T AT03800398 T AT 03800398T AT E400602 T1 ATE400602 T1 AT E400602T1
Authority
AT
Austria
Prior art keywords
thiosulfonate
compositions
hydrogels
forming
hydrogel
Prior art date
Application number
AT03800398T
Other languages
English (en)
Inventor
Michael Bentley
Zhihao Fang
Original Assignee
Nektar Therapeutics Al Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics Al Corp filed Critical Nektar Therapeutics Al Corp
Application granted granted Critical
Publication of ATE400602T1 publication Critical patent/ATE400602T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/334Polymers modified by chemical after-treatment with organic compounds containing sulfur
    • C08G65/3342Polymers modified by chemical after-treatment with organic compounds containing sulfur having sulfur bound to carbon and hydrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001Use of materials characterised by their function or physical properties
    • A61L24/0031Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/046Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/24Crosslinking, e.g. vulcanising, of macromolecules
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2300/00Characterised by the use of unspecified polymers
    • C08J2300/14Water soluble or water swellable polymers, e.g. aqueous gels
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2381/00Characterised by the use of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing sulfur with or without nitrogen, oxygen, or carbon only; Polysulfones; Derivatives of such polymers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00Applications
    • C08L2203/02Applications for biomedical use

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Polyethers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Colloid Chemistry (AREA)
AT03800398T 2002-12-31 2003-12-31 Verfahren zur herstellung von hydrogelen aus thiosulfonat-zusammensetzungen und ihre verwendungen ATE400602T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43725202P 2002-12-31 2002-12-31

Publications (1)

Publication Number Publication Date
ATE400602T1 true ATE400602T1 (de) 2008-07-15

Family

ID=32713157

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03800398T ATE400602T1 (de) 2002-12-31 2003-12-31 Verfahren zur herstellung von hydrogelen aus thiosulfonat-zusammensetzungen und ihre verwendungen

Country Status (6)

Country Link
US (5) US7312301B2 (de)
EP (1) EP1578843B1 (de)
AT (1) ATE400602T1 (de)
AU (1) AU2003300140A1 (de)
DE (1) DE60322111D1 (de)
WO (1) WO2004060967A1 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60322111D1 (de) 2002-12-31 2008-08-21 Nektar Therapeutics Al Co Verfahren zur herstellung von hydrogelen aus thiosulfonat-zusammensetzungen und ihre verwendungen
BRPI0407882B1 (pt) * 2003-02-26 2021-07-27 Nektar Therapeutics Composição compreendendo conjugados de polímero-porção de fator viii e seu método de fabricação
EP1615665A4 (de) * 2003-04-10 2010-10-06 3M Innovative Properties Co Abgabe von die immunantwort modifizierenden verbindungen
JP2007514644A (ja) * 2003-04-10 2007-06-07 スリーエム イノベイティブ プロパティズ カンパニー 免疫反応を向上させる方法および組成物
KR101276422B1 (ko) 2004-03-15 2013-06-19 넥타르 테라퓨틱스 Hiv 유입 억제제의 중합체-기재 조성물 및 콘쥬게이트
EP1796602A4 (de) * 2004-09-17 2016-10-19 Angiotech Pharm Inc Multifunktionelle verbindungen zur erzeugung vernetzter biomaterialien sowie herstellungs- und verwendungsverfahren dafür
US20070060658A1 (en) * 2005-08-31 2007-03-15 Diaz David D Stabilization of organogels and hydrogels by azide-alkyne [3+2] cycloaddition
EP2364735A3 (de) 2005-12-16 2012-04-11 Nektar Therapeutics Verzweigte PEG-Kon jugate von GLP-1
US7671067B2 (en) 2006-02-09 2010-03-02 Enzon Pharmaceuticals, Inc. Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamtothecin
US7462627B2 (en) 2006-02-09 2008-12-09 Enzon Pharmaceuticals, Inc. Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
JP2010500917A (ja) 2006-06-15 2010-01-14 マイクロベンション, インコーポレイテッド 膨張性ポリマーで構成される塞栓形成デバイス
EP1891941A1 (de) * 2006-08-11 2008-02-27 OctoPlus Technologies B.V. Wässrige Gele enthaltend Mikrokügelchen
KR20090108082A (ko) 2007-02-09 2009-10-14 엔존 파마슈티컬즈, 인코포레이티드 7-에틸-10-하이드록시캄토테신 다분지형 고분자 접합체를 이용한 내성 또는 불응성 암의 치료방법
US20080287633A1 (en) * 2007-05-18 2008-11-20 Drumheller Paul D Hydrogel Materials
US8067028B2 (en) * 2007-08-13 2011-11-29 Confluent Surgical Inc. Drug delivery device
AU2008345590B2 (en) 2007-12-21 2014-10-30 Microvention, Inc. Hydrogel filaments for biomedical uses
US20100112014A1 (en) * 2008-04-11 2010-05-06 Gilbert Ryan J Novel hydrogel compositions and methods of using
US20100040672A1 (en) * 2008-06-09 2010-02-18 Northwestern University Delivery of therapeutics
US10799593B2 (en) 2008-06-09 2020-10-13 Northwestern University Nanodiamond particle complexes
AU2009282413B2 (en) 2008-08-11 2014-07-17 Nektar Therapeutics Multi-arm polymeric alkanoate conjugates
US8429349B2 (en) * 2008-09-18 2013-04-23 International Business Machines Corporation Techniques for cache injection in a processor system with replacement policy position modification
US8443146B2 (en) * 2008-09-18 2013-05-14 International Business Machines Corporation Techniques for cache injection in a processor system responsive to a specific instruction sequence
BRPI1014645B1 (pt) 2009-04-30 2020-07-07 Technip France método e sistema para compartilhar linhas de amarração
CN102791183B (zh) 2009-10-26 2015-07-08 微排放器公司 由可膨胀的聚合物构成的栓塞装置
WO2011065916A1 (en) * 2009-11-24 2011-06-03 Agency For Science, Technology And Research Crosslinking branched molecule through thiol-disulfide exchange to form hydrogel
US8524215B2 (en) * 2010-08-02 2013-09-03 Janssen Biotech, Inc. Absorbable PEG-based hydrogels
WO2012088445A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
WO2012088422A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
US9456823B2 (en) 2011-04-18 2016-10-04 Terumo Corporation Embolic devices
CA2848142C (en) 2011-09-07 2021-05-18 Prolynx Llc Hydrogels with biodegradable crosslinking
WO2013158781A1 (en) 2012-04-18 2013-10-24 Microvention, Inc. Embolic devices
AU2013274199B2 (en) 2012-06-14 2016-08-11 Microvention, Inc. Polymeric treatment compositions
CA2870170C (en) 2012-09-12 2018-06-12 Boston Scientific Scimed, Inc. Adhesive stent coating for anti-migration
WO2014059446A1 (en) * 2012-10-12 2014-04-17 Case Western Reserve University Biodegradable hydrogel for polynucleotide delivery
WO2014062696A1 (en) 2012-10-15 2014-04-24 Microvention, Inc. Polymeric treatment compositions
WO2015020676A1 (en) 2013-08-08 2015-02-12 Boston Scientific Scimed, Inc. Dissolvable or degradable adhesive polymer to prevent stent migration
US10173375B2 (en) 2014-03-05 2019-01-08 Bacterin International, Inc. Shaped fiber-based products and method of manufacture thereof
WO2015153996A1 (en) 2014-04-03 2015-10-08 Micro Vention, Inc. Embolic devices
EP3137124B1 (de) 2014-04-29 2019-01-09 Microvention, Inc. Polymere mit wirkstoffen
US10092663B2 (en) 2014-04-29 2018-10-09 Terumo Corporation Polymers
US11046828B2 (en) * 2015-04-21 2021-06-29 Trustees Of Tufts College Fabrication of macroporous monodisperse hydrogel microspheres
WO2016201250A1 (en) 2015-06-11 2016-12-15 Microvention, Inc. Expansile device for implantation
US10821004B2 (en) * 2015-06-30 2020-11-03 Bacterin Interational, Inc. Expandable bone grafts and methods of manufacture thereof
US10368874B2 (en) 2016-08-26 2019-08-06 Microvention, Inc. Embolic compositions
CN107602432B (zh) * 2017-10-01 2019-06-07 刘云晖 一种可溶性水凝胶用交联剂及其制备方法和应用
JP7362598B2 (ja) 2017-10-09 2023-10-17 マイクロベンション インコーポレイテッド 放射性液体塞栓物質
CN119970617A (zh) 2019-04-05 2025-05-13 普罗林科斯有限责任公司 改良偶联接头
WO2021006426A1 (ko) * 2019-07-09 2021-01-14 연세대학교 산학협력단 생체모사 조직 접착성 하이드로젤 패치 및 이의 용도
CN111388748B (zh) * 2020-03-03 2021-08-06 东华大学 一种抗菌止血多功能复合水凝胶敷料及其制备方法
AU2022205377A1 (en) 2021-01-08 2023-07-20 Cellanome, Inc. Devices and methods for analyzing biological samples
US12576400B2 (en) 2021-01-08 2026-03-17 Cellanome, Inc. Methods for incubating and analyzing a cell in a compartment of a fluidic device
WO2025128916A1 (en) * 2023-12-13 2025-06-19 Cellanome, Inc. Devices and methods for analyzing biological samples

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE598976A (de) * 1960-01-11
DE1223156B (de) * 1961-05-27 1966-08-18 Hoechst Ag Verfahren zur Herstellung von hoehermolekularen Polykondensaten
CS159361B1 (de) * 1970-09-08 1975-01-31
IE49097B1 (en) * 1978-11-10 1985-07-24 Ic Gas Int Ltd Thermal energy storage material
NZ193221A (en) * 1979-03-21 1984-08-24 M P Embrey Controlled release composition
JPS60114584A (ja) * 1983-11-25 1985-06-21 Otsuka Chem Co Ltd チオスルホナ−ト誘導体の製造法
JP2664153B2 (ja) * 1987-06-05 1997-10-15 富士写真フイルム株式会社 ハロゲン化銀カラー写真感光材料およびその現像処理方法
US4983579A (en) * 1988-11-18 1991-01-08 International Flavors & Fragrances Inc. Cyano-substituted sulfur containing compounds, compositions containing same, processes for preparing same and organoleptic uses thereof
DE4014537A1 (de) * 1990-05-07 1991-11-14 Goldschmidt Ag Th Verfahren zur herstellung von hochelastischen, polyurethangruppen aufweisenden schaumstoffen mit verminderter stauchhaerte
US5393798A (en) * 1992-06-05 1995-02-28 Spenco Medical Corporation Hydrogel material and method of preparation
CA2137561C (en) 1992-07-06 2001-10-23 Thomas R. Sykes Photoactivation of proteins for conjugation purposes
US5672662A (en) * 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
JP4078032B2 (ja) 1998-03-12 2008-04-23 ネクター セラピューティックス エイエル,コーポレイション 近位の反応性基を持つポリ(エチレングリコール)誘導体
DE69939538D1 (de) * 1998-07-02 2008-10-23 Univ Toronto Mit einer kohlenhydratgruppe chemisch modifizierte proteine
US6131274A (en) * 1999-07-01 2000-10-17 3Com Corporation Apparatus and method for guiding a circuit board into an electronic chassis
DK1455839T3 (da) 1999-10-08 2013-05-06 Nektar Therapeutics Heterobifunktioneller poly(ethylenglycol)-derivater og fremgangsmåder til fremstilling heraf
GB2374072B (en) * 2000-06-16 2004-09-22 Nippon Catalytic Chem Ind Crosslinked polymer method for manufacturing it and use thereof
JP2002049123A (ja) * 2000-08-04 2002-02-15 Fuji Photo Film Co Ltd 熱現像感光材料および画像形成方法
WO2002026170A2 (en) * 2000-09-26 2002-04-04 Neurortho Implants Design, Llc Inter-vertebral disc prosthesis for lumbar rachis through posterior surgery thereof
TW593427B (en) * 2000-12-18 2004-06-21 Nektar Therapeutics Al Corp Synthesis of high molecular weight non-peptidic polymer derivatives
US7053150B2 (en) * 2000-12-18 2006-05-30 Nektar Therapeutics Al, Corporation Segmented polymers and their conjugates
DE60322111D1 (de) 2002-12-31 2008-08-21 Nektar Therapeutics Al Co Verfahren zur herstellung von hydrogelen aus thiosulfonat-zusammensetzungen und ihre verwendungen

Also Published As

Publication number Publication date
US8097695B2 (en) 2012-01-17
EP1578843A1 (de) 2005-09-28
EP1578843B1 (de) 2008-07-09
US8450390B2 (en) 2013-05-28
WO2004060967A1 (en) 2004-07-22
US20120088927A1 (en) 2012-04-12
US20050143484A1 (en) 2005-06-30
US7312301B2 (en) 2007-12-25
US8247598B2 (en) 2012-08-21
AU2003300140A1 (en) 2004-07-29
US7598338B2 (en) 2009-10-06
US20080033105A1 (en) 2008-02-07
DE60322111D1 (de) 2008-08-21
US20120289609A1 (en) 2012-11-15
US20100004424A1 (en) 2010-01-07

Similar Documents

Publication Publication Date Title
ATE400602T1 (de) Verfahren zur herstellung von hydrogelen aus thiosulfonat-zusammensetzungen und ihre verwendungen
DE60314865D1 (de) Verfahren zur herstellung von modifiziertem polymer, danach erhaltenes modifiziertes polymer und kautschukzusammensetzung
DE50309432D1 (de) Verfahren zur herstellung von wässrigen dispersionen
DE60222741D1 (de) Verfahren zur herstellung von beschichteter polymerfolie
EA200600440A1 (ru) 4-((феноксиалкил)тио)еноксиуксусные кислоты и их аналоги
ATE427342T1 (de) Modifizierte pigmente, ein verfahren zur herstellung von modifizierten pigmenten und sie enthaltende tintenzusammensetzungen
AR038563A1 (es) Composicion de ziprasidona y controles sinteticos
ATE547101T1 (de) Verfahren zur verwendung von diketopiperazinen und zusammensetzungen, die diese enthalten
ATE480643T1 (de) Homogener nachweis von analyten
CY1108378T1 (el) 4-υποκατεστημενα παραγωγα 1-αμινοκυκλοεξανιου για την χρησιμοποιηση σαν προσδεματα υποδοχεα orl1 ή οπιακου υποδοχεα mu
ECSP045255A (es) Cumarinas utiles como biomarcadores
BRPI0518334A2 (pt) composiÇço de revestimento, mÉtodo de revestimento, revestimento, e, mÉtodo para preparar uma composiÇço de revestimento
PT1560812E (pt) Compostos de aminociclohexil eter e suas utilizacoes
DE69821376D1 (de) Verfahren zur proteinrückfaltung durch verwendung zwitterionischer wirkstoffe von niedrigem molekulargewicht
DE60326022D1 (de) Verfahren zur Herstellung von leitfähigen thermoplastischen Zusammensetzungen
ATE309283T1 (de) Wässrige dispersion und ihre verwendung zur herstellung von thermisch und mit aktinischer strahlung härtbaren beschichtungsstoffen, klebstoffen und dichtmassen
ATE322826T1 (de) Verfahren zur herstellung von pastenextrudierten sulfonamidzusammensetzungen
PL374494A1 (en) A water-soluble polymer dispersion and a method of producing a water-soluble polymer dispersion
DE50303392D1 (de) Beschichtungszusammensetzung, insbesondere für glasoberflächen, und verfahren zu deren herstellung und verwendung
DE60326907D1 (de) Fotoempfindliche Kunststoffzusammensetzung, Verfahren zur Herstellung von Reliefmustern, und elektronische Bauteile
DE60334875D1 (de) Verfahren zur Herstellung von Fluorpolymerzusammensetzungen welche anorganische Nanopartikel enthalten
TW200643622A (en) Antireflective hardmask composition and methods for using same
DE50301594D1 (de) Verfahren zur Herstellung von Emulsionspolymeren mit hoher Reinheit
BR0209950A (pt) Composição estabilizadora finamente distribuìda para polìmeros contendo halogênio
DE60228400D1 (de) Verfahren zur Herstellung von modifiziertem Polymerkautschuk

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties